THINK Surgical’s Next-Generation Robot System 1st Knee Replacement Procedure Performed at Hackensack University Medical Center

THINK Surgical's TSolution One® Robot Features Unmatched Choice of Implant Options

THINK Surgical’s Next-Generation Robot System: Hackensack University Medical Center, a national leader in orthopedic care and robotic surgery, recently completed the first total knee replacement on the East Coast using the newest generation of the TSolution One robot from THINK Surgical. The system, manufactured by the Fremont, CA – based company features a true, active robot which supports a choice of knee implants from multiple manufacturers in its open implant library.

The procedure was performed by Yair D. Kissin, M.D.*, vice chair, Department of Orthopedics at Hackensack Meridian Health Hackensack University Medical Center. Dr. Kissin praised the system saying, “I am pleased to be able to offer this state-of-the-art technology to my patients. The robot makes incredibly accurate cuts which is important to ensure proper fit of the implant and avoid loosening that can occur with poor cuts.  In addition, the open platform allows me unrivaled choices to personalize the procedure for each patient.”

“We are thrilled to work with Dr. Kissin and the orthopedics team at Hackensack University Medical Center,” said Stuart Simpson, CEO of THINK Surgical, Inc. “Our active robot system helps surgeons perform total knee replacement procedures with unrivaled accuracy. Just as important, the system incorporates an open implant library, which allows surgeons to choose the implant best suited for their patients from an array of companies.”

“Hackensack University Medical Center is proud to be at the forefront of robotic technology and orthopedic surgery,” added Mark D. Sparta, FACHE, president and chief hospital executive, Hackensack University Medical Center and executive vice president of Population Health, Hackensack Meridian Health.” The addition of this active robot delivers the type of leading-edge care we strive to provide for our patients.”

The TSolution One® Total Knee Application combines two exclusive innovations to advance total joint replacement surgery. The system consists of TPLAN®, a 3D pre-surgical planning workstation and TCAT®, an active robot. The pre-surgical planning allows the surgeon to design and prepare the patient’s unique joint replacement in a virtual environment plan leveraging a choice of implant options. During the joint replacement surgery, the surgeon implements the patient’s pre-planned procedure using the active robot, which prepares the joint according to the surgeon’s plan delivering precise placement of implants.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”